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ÖZET
Amaç: Obezite prevalansı son on yıllarda gelişmiş ülke-
lerde artmaktadır. Hafif ve orta obezite çeşitli morbidite ile 
birliktedir. Obezitenin ağır formları çeşitli sağlık problem-
leri ile birliktedir. Bu çalışmanın amacı tüp gastrektomi ile 
elde edilen dokudaki histopatolojik lezyonları araştırmak 
ve analiz etmektir.
Yöntemler:  Ekim  2007  ile  haziran  2008  arasında  tüp 
gastrektomi uygulanan 87 cerrahi girişimden elde edilen 
dokular incelendi. Tüm doku örnekleri (mide, karaciğer, 
yağ dokusu) Patoloji bölümünde incelendi. Doku örnekleri 
formalinde fiske edilerek hematoksieln eozinle boyandı.
Bulgular: Kadın/erkek oranı 2/1 idi. Yaşları 31-40 ara-
sında olan geç hastalar en sık etkilenmişti (%39.1). Sık 
rastlanan histopatolojik lezyonlar pariyetal hücre hiperpla-
zisi (%63.2), ülserasyonlar (%34.5), lamina propriada lenf 
nodu hiperplazisi (%33.3), aktif gastrit (%23.0) ve diğer 
lezyonlar (%10.3) oranlarında saptandı. Mide forniks ve 
korpus mukozasındaki pariyetal hücre hiperplazisi obez 
hastalarda en sık rastlanan lezyon idi. Karaciğer biyopsi 
yapılan üç hastada hepatositlerde steatozis saptandı.
Sonuç: Bizim sonuçlarımız obez hastalarda mide forniks 
mukoza ve karaciğer gibi diğer dokuların histopatolojik 
analizi ko-morbiditelerle birlikte bulundu. Obez hastalar-
daki gastrik ve karaciğer lezyonların histopatolojik ince-
lenmesi  lokal  mekanizmaları  ve  hastaların  sonuçlarını 
daha iyi anlamaya yardımcı olabilir.
Anahtar kelimeler: Ağır obezite, tüp gastrektomi, histo-
patoloji, lezyonlar
ABSTRACT
Objectives: The prevalence of obesity has been increas-
ing in recent decades in developed countries. Slight and 
moderate obesity is associated with various co-morbid-
ities. The most severe forms of obesity are consistently 
associated with the development of various health prob-
lems. The aim of this study was to investigate and analyze 
the most important histopathological lesions obtained by 
sleeve gastrectomy postoperatively.
Materials  and  methods:  We  investigated  87  surgical 
interventions, performed between October of 2007 and 
June  of  2008  for  bariatric  therapy  procedures,  using 
sleeve gastrectomy. All the specimens (gastric, liver and 
adipose tissue) were processed in the Pathology Depart-
ment. The specimens were fixed in buffered formalin, and 
then stained with hematoxilin eosin.
Results: The female to male ratio was 2/1. Young patients 
aged between 31-40 years were most frequently (39.1%) 
affected. The frequent histopathological lesions were pari-
etal cells hyperplasia (63.2%), ulcerations (34.5%), lymph 
nodes hyperplasia in lamina propria (33.3%), active gas-
tritis (23.0%) and other lesions (10.3%). The parietal cells 
hyperplasia found in fornix and corpus mucosa was the 
most frequent lesion encountered in obese patients. All 
three cases showed an important steatosis of the hepato-
cytes by liver biopsy. 
Conclusions: Our results suggest that the histopathol-
ogy analysis of the gastric mucosa of the fornix and other 
tissues (as the liver) is relevant for the comorbidities of the 
obese patients. The evaluation of the histopathological 
gastric and liver aspects could improve the understanding 
of the local mechanism and the outcome of the patients.
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INTRODUCTION
According to the World Health Organization, there 
are an estimated 1 billion adults who are overweight 
(body mass index, BMI>25 kg/m2), and 300 million 
of these are considered clinically obese (BMI>30 kg/
m2)1. Such staggering statistics clearly suggest that, 
despite the overt recognition of the taxing effects of 
obesity on both medical and social programs, West-
ernized societies are still succumbing to this global 
epidemic1. While technological progress made over 
the last 20 years has yielded the tools necessary to 
comprehensively explore the perturbed biochemis-
try underlying the obesity, it has also demonstrated 
that interactions between genetic background and 
environment are critical for the regulation of adi-
pose mass function2. However, prior to our society 
realizing either of these ambitious concepts, the ge-
netic components underlying common diseases such 
as obesity must be elucidated with confidence3.
There are several types of obesity4. Monogenic 
obesity, which is associated with a single gene mu-
tation, has been described in 200 cases. These cases, 
which abide by the Mendelian laws, are character-
ized in children by extremely severe phenotypes, 
and are associated frequently with behavioral, de-
velopment and endocrine disturbances5.
Syndromic obesity: There are 20-30 illnesses 
with Mendelian inheritance in which the patients 
are obese, are mentally retarded, have dysmorphic 
features  and  development  anomalies  specific  to 
each organ. The analysis of the genetic component 
of these diseases suggests that multiple genes can 
produce identical phenotypes. The most known dis-
eases  are  the  Prader-Willi  Syndrome  (PWS),  the 
Bardet-Biedl Syndrome and the Alström syndrome, 
but a few more have been reported6.
Polygenic obesity, or common, regular obesity, 
appears when the genetic mark of an individual is 
influenced by the environment, conditioning a low 
consumption of energy and a great weight gain. In 
order to understand the genetics - environment in-
teractions, several studies have been initiated based 
on the analysis of the polymorphism of nucleotides 
(SNP), or of the repetitions of the bases (poliCA / 
adenine cytosine or microsatellites) at the level of 
the candidate genes7. Unlike with monogenic obe-
sity, in the case of common obesity, many genes and 
chromosomal regions contribute to the obese phe-
notype8.
Bariatric surgery is an option in severely obese 
patients, where lifestyle/medication has not been ef-
fective9. Surgery can be combined with other treat-
ments. Referrals are usually made via a specialist to 
obesity management service10.
There  are  clear  guidelines  from  NICE  about 
who should be considered for bariatric surgery10,11. 
Research suggests that it may be worthwhile for 
those with a BMI over 30-35. The risk/benefit ratio 
is less certain for the young, the elderly and those 
with a BMI >70.
Our study emphasizes the most frequent histo-
pathological lesions detected post surgery, on gastric 
wall specimens, and liver tissue. The histopathology 
report is more detailed than the report provided by 
endoscopy and offers a wide spectrum of lesions ac-
cording to the pathological status and the outcome 
of the patients.
MATERIALS AND METHODS
Between  October  of  2007  and  June  of  2008,  87 
surgical interventions were registered for bariatric 
therapy procedures, using only sleeve gastrectomy, 
for morbid obesity diagnosis.
All  these  cases  were  processed  using  only 
sleeve  gastrectomy  (LSG).  LSG  involves  a  lon-
gitudinal resection of the stomach on the greater 
curvature from the antrum starting opposite of the 
nerve of Latarjet up to the angle of His12,13. The gas-
tric fornix contains 10 to 20 times more ghrelin per 
1×g of tissue than the duodenum with diminishing 
concentrations being found in the jejunum and il-
eum14. The devascularisation of the greater curve 
is performed using a high complex device named 
LigaSure Atlas. The part of the stomach along its 
greater  curve  is  resected.  The  stomach  is  “tubu-
lized” with a residual volume of about 150 ml. This 
volume reduction provides the restricted food in-
take15. This type of gastric resection is anatomically 
and functionally irreversible16,17,18. The rational for 
starting closer to the pylorus and using a small cali-
bre bougie to fashion the gastric tube is to increase 
the restrictive character of the procedure. The use 
of the staplers allows a mechanical three layers su-
ture and then, for a perfect haemostasis a manual 
continuous suture is used. During the surgery, other 
interventions were registered, for other conditions; 
colecystectomies  (4/87),  hiatal  hernia  (5/87),  ab-
dominoplasty (2/87), abdominal hernias (3/87) and C.D. Vrabie et al. Gastric lesions in obese patients 99
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a liver biopsy (3/87). Written informed consent was 
obtained from the patients before processing and 
analyzing the specimens, using consent forms and 
protocols approved by the Hospital Committee of 
Ethics in Medical Research.
All  the  specimens  (gastric  and  liver  tissue) 
were brought into the Pathology Department, fixed 
and examined using hematoxylin eosin stain. We 
performed the histopathology on 6 slices of gastric 
fornix wall and liver tissues. It was performed the 
standard  hematoxilin  eosin  stain.  Mayer’s  hema-
toxylin is used because it eliminates the necessity 
for differentiation and bluing of the section. It can 
be considered a progressive stain, which produces a 
stained section with a clearly defined nucleus while 
the background is completely colorless. The biggest 
objection to Mayer’s hematoxylin as used in the past 
was that stained slides often became fade after 1 to 
3 years. This problem can be eliminated, however, 
when the slides are washed, after the hematoxylin, 
in running water for a minimum of 20 minutes.
This method gives consistent results even when 
more than one person stains sections from the same 
block. Also, slides may be left in the hematoxylin 
for hour without over staining.
The cutting of paraffin blocks has been done on 
the microtom, thickness of 4-5 µ. As an adhesives 
used to attach sections onto the slides we had egg 
albumin. Then we have analysed the slides on the 
Nikon microscope Elipse 200.
RESULTS
The investigated and treated patients were 58 fe-
males and 29 men. The range of the age showed the 
following distribution (Figure 1)
On macroscopic examination we noticed a di-
verse amount of blood within the cavity of the stom-
ach (Table 1). The blood content of the stomach is 
the consequence of the revascularization after the 
removal of the LigaSure Atlas.
Table 1. The repartition of the cases according to 
the blood amount within the gastric cavity
Blood content of the stomach No of cases (21)
Massive hemorrhage (100 ml) 14
Moderate hemorrhage (50 ml) 4
Low hemorrhage (15 ml) 3
Figure 1. The distribution of patients’ ages
Other  lesions  registered  during  the  macro-
scopic examination were atrophy gastritis (2 cases) 
and gastric ulcerations (5 cases). The microscopic 
examination, on hematoxilin eosin stain, revealed a 
range of lesions of the gastric wall, especially on the 
mucosal and submucosal layer (Figure 2).
Figure 2. The main gastric mucosal lesions post 
gastrectomy
We noticed that the most frequent lesion was 
the hyperplasia of the parietal cells, especially at the 
gastric fundus (Figure 3, Figure 4). In all the three 
cases with hepatic steatosis we noticed important 
cellular lesions on the histologic level (Figure 5, 
Figure 6).C.D. Vrabie et al. Gastric lesions in obese patients 100
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Figure 3. Histological aspect of fornix mucosa in a 
patient with morbid obesity. Hematoxilin eosin stain, 
200x.
Figure 4. Aspect of the active gastritis in obese pa-
tient. Hematoxilin eosin stain, 200x.
Figure 5. Histopathology aspect of liver steatosis in 
a patient who underwent bariatric surgery. Hema-
toxilin eosin stain, 200x.
Figure 6. Histopathological pattern in liver steatosis 
in obese patient. Hematoxilin eosin stain, 200x.
DISCUSSION
Obesity is defined as the body mass index over 30 
kg/m2. 1,4 Obesity has become widespread in devel-
oped countries along with a corresponding increase 
in the prevalence of type 2 diabetes. Although the 
precise  underlying  mechanisms  in  the  develop-
ment  of  diabetes  are  as  yet  unknown,  the  initial 
pathophysiological  event  is  usually  insulin  resis-
tance, which involves a genetic component that is 
exacerbated by obesity and a sedentary lifestyle2,3. 
There is a significant risk factors and correlation be-
tween obesity and insulin resistance in nondiabetic 
subjects, and obesity exacerbates insulin resistance 
in diabetic subjects7,8.
Because of these risks and the evidence for risk 
reduction associated with weight loss, the National 
Institutes of Health has recommended weight loss 
surgery as an appropriate alternative in carefully se-
lected individuals with severe obesity (BMI >40 kg/
m2 or those with a BMI >35 kg/m2 and with serious 
comorbid conditions) when dietary, behavioral, and 
pharmacotherapy interventions failed19,20. Bariatric 
surgery results in sustained and significant weight 
loss. The rising prevalence of obesity and the suc-
cess of surgical interventions led to a marked in-
crease in the number of weight-loss surgeries per-
formed in the United States, from 13.365 in 1998 to 
102.794 in 200321.
Society  of  American  Gastrointestinal  Endo-
scopic  Surgeons  has  recently  published  clinical 
guidelines related to the application of laparoscopic 
bariatric operations, where the best available evi-
dence of grading and recommendations for prac-
tice19. The surgical literature awaits the publication C.D. Vrabie et al. Gastric lesions in obese patients 101
Dicle Tıp Derg / Dicle Med J Cilt / Vol 37, No 2, 97-103
of randomized trials comparing the different surgi-
cal therapies. In the absence of such data, present 
study contributed to determine the most appropriate 
surgical procedure by investigating the factors re-
lated to patients and surgery and the relevance of the 
histopathology and the provided data, also. Laparo-
scopic adjustable gastric banding (AGB) is shown 
to have the lowest perioperative risk and the low-
est rate of metabolic complications, but the lowest 
mean potential weight loss. Biliopancreatic diver-
sion with duodenal switch (BPD-DS) provides the 
highest and most durable long-term loss of excess 
body weight, but is the most complex and has the 
highest complication and mortality rate. All proce-
dures improve comorbidities, though BPD-DS and 
Roux-en-Y gastric bypass (RGB) provide the most 
rapid comorbidity improvement. AGB is most re-
versible, and RGB is the least likely to require re-
operation. Experience is accumulating for the sleeve 
gastrectomy (SG) which is safe and results in early 
weight loss and ppears to be comparable with other 
procedures16.
The  gastric  sleeve  laparoscopic  procedure  is 
becoming a well standardized intervention which, 
after going through the learning process, supposes 
an operating time of 60 minutes16,22,23. Sleeve gast-
rectomy was first applied in humans as a component 
of biliopancreatic diversion with duodenal switch 
(BPD-DS) in 198814,24,25. An important advantage 
of this procedure is also the removal of the fun-
dic portion of the stomach, which produces ghre-
lin, a hormone involved in the hunger and fullness 
mechanisms. Consequently, the hunger sensation is 
significantly  reduced.  Besides  the  waiting  period 
from the first few weeks after the surgery, the pa-
tients have little restrictions in what concerns the 
type of food they eat, but the quantity is drastically 
reduced26,27. In comparison with other procedures, 
the sleeve gastrectomy lacks the complications in-
duced by the intestinal by-pass: anemia, deficiencies 
of vitamins and protein and osteoporosis28,29. The 
range of patients to which the procedure is indicated 
is very wide, including those with an extreme body 
mass index, both over 60 or between 30 and 35. The 
sleeve gastrectomy is an irreversible procedure, this 
being its main disadvantage17.
The  most  common  complications  described 
by the literature were dumping syndrome, which 
includes vomiting, reflux, and diarrhea (nearly 20 
percent); anastomosis complications (complications 
resulting from the surgical joining of the intestine 
and stomach), such as leaks or strictures (12 per-
cent); abdominal hernias (7 percent); infections (6 
percent); and pneumonia (4 percent). The overall 
death rate for the entire 180-day postoperative pe-
riod studied was low — 0.2 percent (9,10). Read-
missions of post-obesity surgery patients for these 
conditions increased from 6.5 percent to 10.6 per-
cent between 30 and 180 days9,10.
In the present study, we investigated a group 
of 87 patients who underwent sleeve gastrectomy 
as the surgical procedure for obesity between Octo-
ber of 2007 and June of 2008. The study intends to 
outline the most important histopathological lesions 
found during the postoperative procedure, more rel-
evant when they are provided by a detailed histo-
logical analysis of tissue.
 The selection for treatment with this surgical 
procedure  (longitudinal  sleeve  gastrectomy)  was 
performed only after rigorous laboratory tests were 
carried out in specialized clinics.
In our study, the females are especially affected 
(66%), compared with the males (34%); we consid-
er that women’s addressability and the wish to look 
fine are more relevant than in the case of the men.
The analysis of the age range (Figure 1) shows 
that the most affected are the young patients, be-
tween 31-40 years old (39.1%). It is very important 
to note that this age range at which social accom-
plishment is achieved.
In the present study, the most frequent histo-
pathological  lesions  encountered  on  microscopy 
were parietal cells hyperplasia (63.2%) (Figure 3), 
ulcerations  (34.4%),  lymph  nodes  hyperplasia  in 
lamina  propria  (33.3%),  active  gastritis  (23.0%) 
(Figure 4) and other lesions (10.3%). The oxintic 
cells hyperplasia was noted in the gastric fornix and 
corpus and was the most constant lesion encoun-
tered in obese patients (Figure 2).
Three cases that underwent liver biopsy showed 
notable hepatic steatosis (Figure 5, Figure 6). Non-
alcoholic fatty liver disease is an increasingly rec-
ognized  condition  varying  in  degrees  of  severity 
from mild steatosis to end-stage liver disease30,31,32. 
The term non-alcoholic steatohepatitis (NASH) has 
been used to describe the clinical condition31. NASH 
affects 10 to 24% of the general population in vari-
ous countries30. The prevalence is closely related to C.D. Vrabie et al. Gastric lesions in obese patients 102
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concurrent obesity and disturbances in glucose tol-
erance and insulin resistance33. Insulin resistance is 
linked to the hepatic metabolism of fatty acids and 
concurrent observed dyslipidemia. The susceptibil-
ity to the more advanced forms of NASH is poorly 
understood. Due to the high prevalence of NASH 
in subjects with features of the metabolic syndrome 
and suggested common pathophysiological mecha-
nisms, NASH has been suggested as a new compo-
nent of the metabolic syndrome33.
Our study has focused on two important items: 
firstly,  the  advantages  of  the  surgical  procedure 
used, longitudinal sleeve gastrectomy and second, 
the impact of the informations provided by the pa-
thology report according to the most frequent histo-
pathological gastric lesions.
We consider that the histopathological gastric 
lesions detected after the surgery have an important 
role, taking into account the prognostic pathology 
of the patients. It is well known that the complica-
tions of these surgical procedures are rare, but may 
be serious. Therefore, our study proposes to outline 
that the gastric histopathologic aspects are at least as 
relevant as the preoperative endoscopy is. Despite 
the large number of gastric bypasses performed for 
morbid obesity, very little is known about the his-
tological aspects of the gastric mucosa of obese pa-
tients and the relevance of the lesions for the near 
future outcome post surgery.
For the moment, we have not a histopathologi-
cal database concerning the follow-up of the obese 
patients post surgery in order to compare the gastric 
lesions pre and postoperative but future researches 
can focus on this issue.
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